1 Study Coverage
1.1 Non-invasive Neuromodulation Device Product Introduction
1.2 Market by Type
1.2.1 Global Non-invasive Neuromodulation Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Transcranial Direct Current Stimulation (tDCS)
1.2.3 Transcranial Alternating Current Stimulation (tACS)
1.2.4 Transcranial Pulsed Current Stimulation (tPCS)
1.2.5 Transcranial Random Noise Stimulation (tRNS)
1.2.6 Electroconvulsive therapy (ECT)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Non-invasive Neuromodulation Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non-invasive Neuromodulation Device Sales Estimates and Forecasts 2017-2028
2.2 Global Non-invasive Neuromodulation Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Non-invasive Neuromodulation Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non-invasive Neuromodulation Device Sales by Region
2.4.1 Global Non-invasive Neuromodulation Device Sales by Region (2017-2022)
2.4.2 Global Sales Non-invasive Neuromodulation Device by Region (2023-2028)
2.5 Global Non-invasive Neuromodulation Device Revenue by Region
2.5.1 Global Non-invasive Neuromodulation Device Revenue by Region (2017-2022)
2.5.2 Global Non-invasive Neuromodulation Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non-invasive Neuromodulation Device Sales by Manufacturers
3.1.1 Global Top Non-invasive Neuromodulation Device Manufacturers by Sales (2017-2022)
3.1.2 Global Non-invasive Neuromodulation Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-invasive Neuromodulation Device in 2021
3.2 Global Non-invasive Neuromodulation Device Revenue by Manufacturers
3.2.1 Global Non-invasive Neuromodulation Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non-invasive Neuromodulation Device Revenue in 2021
3.3 Global Non-invasive Neuromodulation Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-invasive Neuromodulation Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-invasive Neuromodulation Device Sales by Type
4.1.1 Global Non-invasive Neuromodulation Device Historical Sales by Type (2017-2022)
4.1.2 Global Non-invasive Neuromodulation Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
4.2 Global Non-invasive Neuromodulation Device Revenue by Type
4.2.1 Global Non-invasive Neuromodulation Device Historical Revenue by Type (2017-2022)
4.2.2 Global Non-invasive Neuromodulation Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)
4.3 Global Non-invasive Neuromodulation Device Price by Type
4.3.1 Global Non-invasive Neuromodulation Device Price by Type (2017-2022)
4.3.2 Global Non-invasive Neuromodulation Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Non-invasive Neuromodulation Device Sales by Application
5.1.1 Global Non-invasive Neuromodulation Device Historical Sales by Application (2017-2022)
5.1.2 Global Non-invasive Neuromodulation Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
5.2 Global Non-invasive Neuromodulation Device Revenue by Application
5.2.1 Global Non-invasive Neuromodulation Device Historical Revenue by Application (2017-2022)
5.2.2 Global Non-invasive Neuromodulation Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)
5.3 Global Non-invasive Neuromodulation Device Price by Application
5.3.1 Global Non-invasive Neuromodulation Device Price by Application (2017-2022)
5.3.2 Global Non-invasive Neuromodulation Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Non-invasive Neuromodulation Device Market Size by Type
6.1.1 North America Non-invasive Neuromodulation Device Sales by Type (2017-2028)
6.1.2 North America Non-invasive Neuromodulation Device Revenue by Type (2017-2028)
6.2 North America Non-invasive Neuromodulation Device Market Size by Application
6.2.1 North America Non-invasive Neuromodulation Device Sales by Application (2017-2028)
6.2.2 North America Non-invasive Neuromodulation Device Revenue by Application (2017-2028)
6.3 North America Non-invasive Neuromodulation Device Market Size by Country
6.3.1 North America Non-invasive Neuromodulation Device Sales by Country (2017-2028)
6.3.2 North America Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Non-invasive Neuromodulation Device Market Size by Type
7.1.1 Europe Non-invasive Neuromodulation Device Sales by Type (2017-2028)
7.1.2 Europe Non-invasive Neuromodulation Device Revenue by Type (2017-2028)
7.2 Europe Non-invasive Neuromodulation Device Market Size by Application
7.2.1 Europe Non-invasive Neuromodulation Device Sales by Application (2017-2028)
7.2.2 Europe Non-invasive Neuromodulation Device Revenue by Application (2017-2028)
7.3 Europe Non-invasive Neuromodulation Device Market Size by Country
7.3.1 Europe Non-invasive Neuromodulation Device Sales by Country (2017-2028)
7.3.2 Europe Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-invasive Neuromodulation Device Market Size by Type
8.1.1 Asia Pacific Non-invasive Neuromodulation Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Non-invasive Neuromodulation Device Revenue by Type (2017-2028)
8.2 Asia Pacific Non-invasive Neuromodulation Device Market Size by Application
8.2.1 Asia Pacific Non-invasive Neuromodulation Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Non-invasive Neuromodulation Device Revenue by Application (2017-2028)
8.3 Asia Pacific Non-invasive Neuromodulation Device Market Size by Region
8.3.1 Asia Pacific Non-invasive Neuromodulation Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Non-invasive Neuromodulation Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Non-invasive Neuromodulation Device Market Size by Type
9.1.1 Latin America Non-invasive Neuromodulation Device Sales by Type (2017-2028)
9.1.2 Latin America Non-invasive Neuromodulation Device Revenue by Type (2017-2028)
9.2 Latin America Non-invasive Neuromodulation Device Market Size by Application
9.2.1 Latin America Non-invasive Neuromodulation Device Sales by Application (2017-2028)
9.2.2 Latin America Non-invasive Neuromodulation Device Revenue by Application (2017-2028)
9.3 Latin America Non-invasive Neuromodulation Device Market Size by Country
9.3.1 Latin America Non-invasive Neuromodulation Device Sales by Country (2017-2028)
9.3.2 Latin America Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-invasive Neuromodulation Device Market Size by Type
10.1.1 Middle East and Africa Non-invasive Neuromodulation Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Non-invasive Neuromodulation Device Market Size by Application
10.2.1 Middle East and Africa Non-invasive Neuromodulation Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Non-invasive Neuromodulation Device Market Size by Country
10.3.1 Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Neuroelectrics
11.1.1 Neuroelectrics Corporation Information
11.1.2 Neuroelectrics Overview
11.1.3 Neuroelectrics Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Neuroelectrics Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Neuroelectrics Recent Developments
11.2 Magstim
11.2.1 Magstim Corporation Information
11.2.2 Magstim Overview
11.2.3 Magstim Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Magstim Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Magstim Recent Developments
11.3 NeuroCare Group
11.3.1 NeuroCare Group Corporation Information
11.3.2 NeuroCare Group Overview
11.3.3 NeuroCare Group Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 NeuroCare Group Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 NeuroCare Group Recent Developments
11.4 Soterix Medical
11.4.1 Soterix Medical Corporation Information
11.4.2 Soterix Medical Overview
11.4.3 Soterix Medical Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Soterix Medical Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Soterix Medical Recent Developments
11.5 Newronika
11.5.1 Newronika Corporation Information
11.5.2 Newronika Overview
11.5.3 Newronika Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Newronika Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Newronika Recent Developments
11.6 Rogue Resolutions
11.6.1 Rogue Resolutions Corporation Information
11.6.2 Rogue Resolutions Overview
11.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Rogue Resolutions Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Rogue Resolutions Recent Developments
11.7 Medtronic
11.7.1 Medtronic Corporation Information
11.7.2 Medtronic Overview
11.7.3 Medtronic Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Medtronic Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medtronic Recent Developments
11.8 Philips Healthcare
11.8.1 Philips Healthcare Corporation Information
11.8.2 Philips Healthcare Overview
11.8.3 Philips Healthcare Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Philips Healthcare Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Philips Healthcare Recent Developments
11.9 Shenzhen Yingchi Technology
11.9.1 Shenzhen Yingchi Technology Corporation Information
11.9.2 Shenzhen Yingchi Technology Overview
11.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shenzhen Yingchi Technology Recent Developments
11.10 Shenzhen Hanix United
11.10.1 Shenzhen Hanix United Corporation Information
11.10.2 Shenzhen Hanix United Overview
11.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Shenzhen Hanix United Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shenzhen Hanix United Recent Developments
11.11 Shanghai Qiankang Medical Care Company
11.11.1 Shanghai Qiankang Medical Care Company Corporation Information
11.11.2 Shanghai Qiankang Medical Care Company Overview
11.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai Qiankang Medical Care Company Recent Developments
11.12 TCT Research
11.12.1 TCT Research Corporation Information
11.12.2 TCT Research Overview
11.12.3 TCT Research Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 TCT Research Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 TCT Research Recent Developments
11.13 EB Neuro SpA
11.13.1 EB Neuro SpA Corporation Information
11.13.2 EB Neuro SpA Overview
11.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 EB Neuro SpA Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 EB Neuro SpA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-invasive Neuromodulation Device Industry Chain Analysis
12.2 Non-invasive Neuromodulation Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-invasive Neuromodulation Device Production Mode & Process
12.4 Non-invasive Neuromodulation Device Sales and Marketing
12.4.1 Non-invasive Neuromodulation Device Sales Channels
12.4.2 Non-invasive Neuromodulation Device Distributors
12.5 Non-invasive Neuromodulation Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-invasive Neuromodulation Device Industry Trends
13.2 Non-invasive Neuromodulation Device Market Drivers
13.3 Non-invasive Neuromodulation Device Market Challenges
13.4 Non-invasive Neuromodulation Device Market Restraints
14 Key Findings in The Global Non-invasive Neuromodulation Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Non-invasive Neuromodulation Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Transcranial Direct Current Stimulation (tDCS)
Table 3. Major Manufacturers of Transcranial Alternating Current Stimulation (tACS)
Table 4. Major Manufacturers of Transcranial Pulsed Current Stimulation (tPCS)
Table 5. Major Manufacturers of Transcranial Random Noise Stimulation (tRNS)
Table 6. Major Manufacturers of Electroconvulsive therapy (ECT)
Table 7. Major Manufacturers of Others
Table 8. Global Non-invasive Neuromodulation Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Non-invasive Neuromodulation Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Non-invasive Neuromodulation Device Sales by Region (2017-2022) & (K Units)
Table 11. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2017-2022)
Table 12. Global Non-invasive Neuromodulation Device Sales by Region (2023-2028) & (K Units)
Table 13. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2023-2028)
Table 14. Global Non-invasive Neuromodulation Device Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Non-invasive Neuromodulation Device Revenue Market Share by Region (2017-2022)
Table 16. Global Non-invasive Neuromodulation Device Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Non-invasive Neuromodulation Device Revenue Market Share by Region (2023-2028)
Table 18. Global Non-invasive Neuromodulation Device Sales by Manufacturers (2017-2022) & (K Units)
Table 19. Global Non-invasive Neuromodulation Device Sales Share by Manufacturers (2017-2022)
Table 20. Global Non-invasive Neuromodulation Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Non-invasive Neuromodulation Device Revenue Share by Manufacturers (2017-2022)
Table 22. Non-invasive Neuromodulation Device Price by Manufacturers (2017-2022) &(US$/Unit)
Table 23. Global Non-invasive Neuromodulation Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Non-invasive Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Neuromodulation Device as of 2021)
Table 25. Non-invasive Neuromodulation Device Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Non-invasive Neuromodulation Device Product Offered
Table 27. Date of Manufacturers Enter into Non-invasive Neuromodulation Device Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 30. Global Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 31. Global Non-invasive Neuromodulation Device Sales Share by Type (2017-2022)
Table 32. Global Non-invasive Neuromodulation Device Sales Share by Type (2023-2028)
Table 33. Global Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Non-invasive Neuromodulation Device Revenue Share by Type (2017-2022)
Table 36. Global Non-invasive Neuromodulation Device Revenue Share by Type (2023-2028)
Table 37. Non-invasive Neuromodulation Device Price by Type (2017-2022) & (US$/Unit)
Table 38. Global Non-invasive Neuromodulation Device Price Forecast by Type (2023-2028) & (US$/Unit)
Table 39. Global Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 40. Global Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 41. Global Non-invasive Neuromodulation Device Sales Share by Application (2017-2022)
Table 42. Global Non-invasive Neuromodulation Device Sales Share by Application (2023-2028)
Table 43. Global Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Non-invasive Neuromodulation Device Revenue Share by Application (2017-2022)
Table 46. Global Non-invasive Neuromodulation Device Revenue Share by Application (2023-2028)
Table 47. Non-invasive Neuromodulation Device Price by Application (2017-2022) & (US$/Unit)
Table 48. Global Non-invasive Neuromodulation Device Price Forecast by Application (2023-2028) & (US$/Unit)
Table 49. North America Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 50. North America Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 51. North America Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 54. North America Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 55. North America Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 58. North America Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)
Table 59. North America Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 62. Europe Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 63. Europe Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 66. Europe Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 67. Europe Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 70. Europe Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)
Table 71. Europe Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 74. Asia Pacific Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 75. Asia Pacific Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 78. Asia Pacific Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 79. Asia Pacific Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Non-invasive Neuromodulation Device Sales by Region (2017-2022) & (K Units)
Table 82. Asia Pacific Non-invasive Neuromodulation Device Sales by Region (2023-2028) & (K Units)
Table 83. Asia Pacific Non-invasive Neuromodulation Device Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Non-invasive Neuromodulation Device Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 86. Latin America Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 87. Latin America Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 90. Latin America Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 91. Latin America Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 94. Latin America Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)
Table 95. Latin America Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)
Table 98. Middle East and Africa Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)
Table 99. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)
Table 102. Middle East and Africa Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)
Table 103. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)
Table 106. Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)
Table 107. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (US$ Million)
Table 109. Neuroelectrics Corporation Information
Table 110. Neuroelectrics Description and Major Businesses
Table 111. Neuroelectrics Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Neuroelectrics Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Neuroelectrics Recent Developments
Table 114. Magstim Corporation Information
Table 115. Magstim Description and Major Businesses
Table 116. Magstim Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Magstim Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Magstim Recent Developments
Table 119. NeuroCare Group Corporation Information
Table 120. NeuroCare Group Description and Major Businesses
Table 121. NeuroCare Group Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. NeuroCare Group Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. NeuroCare Group Recent Developments
Table 124. Soterix Medical Corporation Information
Table 125. Soterix Medical Description and Major Businesses
Table 126. Soterix Medical Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Soterix Medical Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Soterix Medical Recent Developments
Table 129. Newronika Corporation Information
Table 130. Newronika Description and Major Businesses
Table 131. Newronika Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Newronika Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Newronika Recent Developments
Table 134. Rogue Resolutions Corporation Information
Table 135. Rogue Resolutions Description and Major Businesses
Table 136. Rogue Resolutions Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Rogue Resolutions Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Rogue Resolutions Recent Developments
Table 139. Medtronic Corporation Information
Table 140. Medtronic Description and Major Businesses
Table 141. Medtronic Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Medtronic Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Medtronic Recent Developments
Table 144. Philips Healthcare Corporation Information
Table 145. Philips Healthcare Description and Major Businesses
Table 146. Philips Healthcare Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Philips Healthcare Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Philips Healthcare Recent Developments
Table 149. Shenzhen Yingchi Technology Corporation Information
Table 150. Shenzhen Yingchi Technology Description and Major Businesses
Table 151. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Shenzhen Yingchi Technology Recent Developments
Table 154. Shenzhen Hanix United Corporation Information
Table 155. Shenzhen Hanix United Description and Major Businesses
Table 156. Shenzhen Hanix United Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Shenzhen Hanix United Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Shenzhen Hanix United Recent Developments
Table 159. Shanghai Qiankang Medical Care Company Corporation Information
Table 160. Shanghai Qiankang Medical Care Company Description and Major Businesses
Table 161. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Shanghai Qiankang Medical Care Company Recent Developments
Table 164. TCT Research Corporation Information
Table 165. TCT Research Description and Major Businesses
Table 166. TCT Research Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 167. TCT Research Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. TCT Research Recent Developments
Table 169. EB Neuro SpA Corporation Information
Table 170. EB Neuro SpA Description and Major Businesses
Table 171. EB Neuro SpA Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 172. EB Neuro SpA Non-invasive Neuromodulation Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. EB Neuro SpA Recent Developments
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Non-invasive Neuromodulation Device Distributors List
Table 177. Non-invasive Neuromodulation Device Customers List
Table 178. Non-invasive Neuromodulation Device Market Trends
Table 179. Non-invasive Neuromodulation Device Market Drivers
Table 180. Non-invasive Neuromodulation Device Market Challenges
Table 181. Non-invasive Neuromodulation Device Market Restraints
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-invasive Neuromodulation Device Product Picture
Figure 3. Global Non-invasive Neuromodulation Device Market Share by Type in 2021 & 2028
Figure 3. Transcranial Direct Current Stimulation (tDCS) Product Picture
Figure 4. Transcranial Alternating Current Stimulation (tACS) Product Picture
Figure 5. Transcranial Pulsed Current Stimulation (tPCS) Product Picture
Figure 6. Transcranial Random Noise Stimulation (tRNS) Product Picture
Figure 7. Electroconvulsive therapy (ECT) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Non-invasive Neuromodulation Device Market Share by Application in 2021 & 2028
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Non-invasive Neuromodulation Device Report Years Considered
Figure 14. Global Non-invasive Neuromodulation Device Sales 2017-2028 (K Units)
Figure 15. Global Non-invasive Neuromodulation Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Non-invasive Neuromodulation Device Revenue 2017-2028 (US$ Million)
Figure 17. Global Non-invasive Neuromodulation Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2017-2022)
Figure 19. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2023-2028)
Figure 20. North America Non-invasive Neuromodulation Device Sales YoY (2017-2028) & (K Units)
Figure 21. North America Non-invasive Neuromodulation Device Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Non-invasive Neuromodulation Device Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Non-invasive Neuromodulation Device Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Non-invasive Neuromodulation Device Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Non-invasive Neuromodulation Device Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Non-invasive Neuromodulation Device Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Non-invasive Neuromodulation Device Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Non-invasive Neuromodulation Device Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Non-invasive Neuromodulation Device Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Non-invasive Neuromodulation Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Non-invasive Neuromodulation Device in the World: Market Share by Non-invasive Neuromodulation Device Revenue in 2021
Figure 32. Global Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 34. Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)
Figure 35. Global Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 36. Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)
Figure 37. North America Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 38. North America Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)
Figure 39. North America Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 40. North America Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)
Figure 41. North America Non-invasive Neuromodulation Device Sales Share by Country (2017-2028)
Figure 42. North America Non-invasive Neuromodulation Device Revenue Share by Country (2017-2028)
Figure 43. United States Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 46. Europe Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)
Figure 47. Europe Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 48. Europe Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)
Figure 49. Europe Non-invasive Neuromodulation Device Sales Share by Country (2017-2028)
Figure 50. Europe Non-invasive Neuromodulation Device Revenue Share by Country (2017-2028)
Figure 51. Germany Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 52. France Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Non-invasive Neuromodulation Device Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Non-invasive Neuromodulation Device Revenue Share by Region (2017-2028)
Figure 62. China Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 65. India Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 72. Latin America Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 74. Latin America Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Non-invasive Neuromodulation Device Sales Share by Country (2017-2028)
Figure 76. Latin America Non-invasive Neuromodulation Device Revenue Share by Country (2017-2028)
Figure 77. Mexico Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Non-invasive Neuromodulation Device Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Non-invasive Neuromodulation Device Revenue Share by Country (2017-2028)
Figure 86. Turkey Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)
Figure 89. Non-invasive Neuromodulation Device Value Chain
Figure 90. Non-invasive Neuromodulation Device Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
